Current Neuro-Oncology

Volume 25 Number 20
31 October 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 20, 31 October

Gordon JA, Pasli M, Cook CM, Connor R, Boyer PJ, Ju AW, Lee KS, Knudson KE, Peach MS.
Novel combination of GammaTile cesium-131 brachytherapy with 5-aminolevulinic acid fluorescence-guided resection in the re-irradiation of pediatric recurrent high-grade glioma: illustrative case.
J Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23346. doi: 10.3171/CASE23346. PMID: 37870768. Case report.

Habiboglu R, Kayali I, Saricanbaz I, Tezcan Y.
Comparative Analysis of IDH Wild-Type Multifocal and Unifocal Glioblastomas: Prognostic Factors and Survival Outcomes in Focus.
Turk Neurosurg. 2023 Oct 16. doi: 10.5137/1019-5149.JTN.45354-23.4. PMID: 37846543. Observational study. ˍ


Ong K, Hounjet C, Makarenko S.
Intraoperative and postoperative complications for repeat high-grade glioma resections with concurrent chemotherapy: patient series.
J Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23341. doi: 10.3171/CASE23341. PMID: 37870760. Case report.

Owusu-Adjei B, Mietus CJ, Lim JC, Lambert W, Daci R, Cachia D, Smith TW, Amenta PS.
Diffusely invasive supratentorial rosette-forming glioneuronal tumor: illustrative case.
J Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23435. doi: 10.3171/CASE23435. PMID: 37870758. Case report.

Tsukamoto Y, Natsumeda M, Takahashi H, Ueno A, Sakai K, Shida K, Seto H, Saito T, Shibuma S, Nakayama Y, Tanaka Y, Nakano T, Ohta A, Maruyama K, Okada M, Eda T, Seki Y, Yoneoka Y, Shimizu H, Okamoto K, Kakita A, Oishi M.
Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative cases.
J Neurosurg Case Lessons. 2023 Oct 16;6(16):CASE23361. doi: 10.3171/CASE23361. PMID: 37870755. Case report. ˍ

Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N, Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B, Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y, Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U, Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K, Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A, Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D, Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D, Tirosh I, Suvà ML, Wucherpfennig KW, Ligon K, Reardon DA, Antonio Chiocca E.
Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
Nature. 2023 Oct 18. doi: 10.1038/s41586-023-06623-2. PMID: 37853118. Interventional study.

Grassl N, Sahm K, Süße H, Poschke I, Bunse L, Bunse T, Boschert T, Mildenberger I, Rupp AK, Ewinger MP, Lanz LM, Denk M, Tabatabai G, Ronellenfitsch MW, Herrlinger U, Glas M, Krex D, Vajkoczy P, Wick A, Harting I, Sahm F, von Deimling A, Bendszus M, Wick W, Platten M.
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas.
Neurol Res Pract. 2023 Oct 19;5(1):55. doi: 10.1186/s42466-023-00282-4. PMID: 37853454. Interventional study protocol. ˍ

Kim N, Lee J, Nam DH, Lee JI, Seol HJ, Kong DS, Choi JW, Chong K, Lee WJ, Chang JH, Kang SG, Moon JH, Cho J, Lim DH, Yoon HI.
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol. 2023 Oct 20. doi: 10.1007/s11060-023-04465-6. PMID: 37861921. Observational study˰

Kulac I, Yenidogan I, Oflaz Sozmen B, Baygul A, Cha S, Pekmezci M, Tihan T.
Pathological perspectives in pilocytic astrocytomas: Extent of resection as the sole critical factor for recurrence-free survival, and the challenge of evaluating conclusions derived from limited data.
Free Neuropathol. 2023 Oct 20;4:4-17. doi: 10.17879/freeneuropathology-2023-5116. PMID: 37901684. Observational study.

Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S.
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
J Neurooncol. 2023 Oct 21. doi: 10.1007/s11060-023-04456-7. PMID: 37864646. Interventional study˰


Yang YC, Chen YS, Liao WC, Yin CH, Lin YS, Chen MW, Chen JS.
Significant perioperative parameters affecting postoperative complications within 30 days following craniotomy for primary malignant brain tumors.
Perioper Med (Lond). 2023 Oct 23;12(1):54. doi: 10.1186/s13741-023-00343-x. PMID: 37872604. Observational study.

Verma P, Singh BK, Sudhan MD, Singh RK, Bagul SD, Chandak AR, Soni BK, Shelly D, Basu S.
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Clin Nucl Med. 2023 Oct 24. doi: 10.1097/RLU.0000000000004903. PMID: 37883060. Observational study˰

White B, Filo J, Orrego-Gonzalez E, Schwartz SN, Varma H, Uhlmann EJ, Vega RA.
Synchronous contralateral low-grade oligodendroglioma and high-grade IDH-mutant astrocytoma.
J Neuropathol Exp Neurol. 2023 Oct 24:nlad088. doi: 10.1093/jnen/nlad088. PMID: 37875098. Letter, Case report.


De Leon-Benedetti L, Narayanan S, Lee VK, Panigrahy A, Boada F, Bhatia A.
The use of sodium MRI in the diagnosis of an anaplastic astrocytoma during immunotherapy: a case report.
Childs Nerv Syst. 2023 Oct 25. doi: 10.1007/s00381-023-06195-6. PMID: 37878058. Case report˰

Grob ST, Miller KR, Sanford B, Donson AM, Jones K, Griesinger AM, Amani V, Foreman NK, Liu A, Handler M, Hankinson TC, Milgrom S, Levy JMM.
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors.
J Neurooncol. 2023 Oct 25. doi: 10.1007/s11060-023-04472-7. PMID: 37878192. Observational study.

Klawinski DM, Cottrell CE, Schieffer KM, Indyk JA, Gandhi K, Mardis ER, Rodriguez DP, Breneman JC, Osorio DS.
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213.
Pediatr Blood Cancer. 2023 Oct 25:e30739. doi: 10.1002/pbc.30739. PMID: 37877896. Case report˰

Nazem A, Lavezo J, Abdullaev Z, Aldape K, Quezado M, Cimino PJ, Pratt DW, Jenkins RB, Ida CM.
Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
J Neuropathol Exp Neurol. 2023 Oct 25:nlad089. doi: 10.1093/jnen/nlad089. PMID: 37878797. Letter, Case report.

Schei S, Sagberg LM, Bø LE, Reinertsen I, Solheim O.
Association between patient-reported cognitive function and location of glioblastoma.
Neurosurg Rev. 2023 Oct 25;46(1):282. doi: 10.1007/s10143-023-02177-z. PMID: 37880432. Observational study.


Stringer BW, De Silva MI, Greenberg Z, Noreña Puerta A, Adams R, Milky B, Zabolocki M, van den Hurk M, Ebert LM, Fairly Bishop C, Conn SJ, Kichenadasse G, Michael MZ, Ormsby RJ, Poonoose S, Bardy C.
Human cerebrospinal fluid affects chemoradiotherapy sensitivities in tumor cells from patients with glioblastoma.
Sci Adv. 2023 Oct 25;9(43):eadf1332. doi: 10.1126/sciadv.adf1332. PMID: 37878712. Observational study.

Krugman J, Patel K, Cantor A, Snuderl M, Cooper B, Zan E, Radmanesh A, Hidalgo ET, Nicolaides T.
Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab.
Pediatr Blood Cancer. 2023 Oct 26:e30757. doi: 10.1002/pbc.30757. PMID: 37881859. Editorial˰

Peyrl A, Chocholous M, Sabel M, Lassaletta A, Sterba J, Leblond P, Nysom K, Torsvik I, Chi SN, Perwein T, Jones N, Holm S, Nyman P, Mörse H, Öberg A, Weiler-Wichtl L, Leiss U, Haberler C, Schmook MT, Mayr L, Dieckmann K, Kool M, Gojo J, Azizi AA, André N, Kieran M, Slavc I.
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
JAMA Oncol. 2023 Oct 26:e234437. doi: 10.1001/jamaoncol.2023.4437. PMID: 37883081. Interventional study.

Ma S, Lee H, Jo WY, Byun YH, Shin KW, Choi S, Oh H, Park CK, Park HP.
The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04486-1. PMID: 37889442. Observational study˰

Mohammad AH, Jatana S, Ruiz-Barerra MA, Khalaf R, Al-Saadi T, Diaz RJ.
Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing.
J Neurooncol. 2023 Oct 27. doi: 10.1007/s11060-023-04485-2. PMID: 37889443. Observational study˰

Xu X, Zhang P, Zhuo Z, Duan Y, Qu L, Cheng D, Sun T, Ding J, Xie C, Liu X, Haller S, Barkhof F, Ye C, Zhang L, Liu Y.
Prediction of H3K27M Alteration Status in Brainstem Glioma Using Multi-Shell Diffusion MRI Metrics.
J Magn Reson Imaging. 2023 Oct 27. doi: 10.1002/jmri.29104. PMID: 37889147. Observational study˰